Violation Tracker Individual Record
Company:
Novo Nordisk Inc.
Current Parent Company:
Novo Holdings A/S
Penalty:
$1,100,000
Year:
2017
Date:
September 5, 2017
Offense Group:
healthcare-related offenses
Primary Offense:
off-label or unapproved promotion of medical products
Secondary Offense:
drug or medical equipment safety violation
Violation Description:
The California Insurance Commissioner reached a $1.1 million settlement with pharmaceutical company Novo Nordisk Inc. over allegations that Novo Nordisk's drug Victoza was extensively promoted for uses not approved of by the Food and Drug Administration, a violation of the Insurance Frauds Prevention Action.
Level of Government:
state
Action Type:
agency action
Agency:
California Department of Insurance
Civil or Criminal Case:
civil
Facility State:
California
HQ Country of Parent:
Denmark
Ownership Structure of Parent:
privately held
Major Industry of Parent:
pharmaceuticals
Specific Industry of Parent:
pharmaceuticals
Source Notes:
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note:
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.
